• About Pharmetheus
    • History
    • Mission & Values
    • Leadership
    • Scientific advisors
    • Our team
    • Social impact (CSR)
    • Contexts of use
      • Trial design and analysis
      • Program strategies and efficiences
      • Special/specific populations
      • Special considerations
      • Regulatory interactions
    • Pharmetheus Platforms
      • Model-Informed Drug Development
      • PBPK & PBBM
      • Pharmacometrics
      • QSP
    • Solutions
      • Milestone Analysis
      • Embedded Scientists
      • Expert Advice
      • Training workshop
      • Scientific Publication
    • Specific services
      • Model-Informed Bioequivalence 
& Biosimilarity
      • Accelerated submission
      • Concentration-QTc (C-QTc) modeling
      • Data-driven strategies for pediatric success
      • Publications
      • Case studies
      • Articles
    • Working with us
    • Open positions
    • Employee stories
    Qing Xi Ooi supports clients with hands-on analysis and strategic advice

    Qing Xi Ooi supports clients with hands-on analysis and strategic advice

    Viviana Moroso brings scientific depth to quality control

    Viviana Moroso brings scientific depth to quality control

    Siv Jönsson develops Pharmetheus’s learning agenda

    Siv Jönsson develops Pharmetheus’s learning agenda

  • Events
  • News
  • Contact us
  1. Home
  2. Science and services
  3. Training workshops
  4. Workshop: Leveraging in vitro data within PBPK

Workshop: Leveraging in vitro data within PBPK

This workshop offers hands-on training in integrating in vitro data into Physiologically-Based Pharmacokinetic (PBPK) modeling for IVIVE and virtual bioequivalence trials.

Overview

This workshop delivers a comprehensive approach to leveraging in vitro data in PBPK modeling for drug development. Participants will learn best practices for integrating preclinical data, understand the IVIVE process, and explore how in vitro dissolution data can inform virtual bioequivalence trials. Hands-on exercises will reinforce learning through real-world case studies.

Workshop goals

Equip participants with a strong foundation in PBPK principles and applications for early drug development, enabling them to apply these techniques effectively in research and regulatory decision-making.

Workshop learning objectives

By the end of this workshop, participants will:

  • Understand the role of PBPK in drug development, particularly for first-in-human PK predictions.

  • Learn to integrate preclinical in vitro and in vivo data for IVIVE and FIH predictions.

  • Use in vitro dissolution data for virtual bioequivalence trials.

Key topics covered

  • PBPK in drug development
  • First-in-human (FIH) PK predictions
  • In vitro-in vivo extrapolation (IVIVE)
  • Preclinical data integration (in vitro, in vivo)
  • Virtual bioequivalence trials using dissolution data

Target audience

This workshop is ideal for professionals interested in PBPK modeling, including scientists involved in drug development, biopharmaceutics experts, and researchers focused on preclinical-to-clinical extrapolation.

Workshop requirements

Participants must bring a laptop with the required software installed. Basic knowledge of pharmacokinetics and modeling is recommended but not required.

Explore our on-demand workshops

Browse our full workshop catalog

Contact

Pharmetheus AB
Kungsängstull 4 

753 19 Uppsala, Sweden

Visiting address: 

Dragarbrunnsgatan 77, 5th floor

  • LinkedIn
  • YouTube
  • Services & Science
    • Contexts of use
    • Pharmetheus Platforms
    • Solutions
    • Specific services
    • Publications
    • Case studies
  • Quick links
    • About us
    • Events
    • News
    • Careers
    • Contact us
    • Newsletter

About Pharmetheus

Pharmetheus is a consultancy firm helping clients reduce uncertainty in technical and regulatory processes, increasing confidence in the development of new medicines that can improve patients’ lives.

Gasell 2017
Gasell 2020
Gasell 2021
Gasell 2022
Gasell 2023
Gasell 2024

Copyright © Pharmetheus AB 2026

  • Whistleblower
  • Privacy Policy
  • Cookie Policy
  • Consent Preferences